Rockwell Medical, Inc. (RMTI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -167K | 2.29M | -1.31M | 1.84M | -3.49M | 865K | 4.28M | 1.44M | -2.38M | -43K | -3.75M | -1.74M |
| Operating CF Margin % | -0% | 12.49% | -8.21% | 11.47% | -18.44% | 3.51% | 15.1% | 5.58% | -10.5% | -0.19% | -15.79% | -9.62% |
| Operating CF Growth % | 95.21% | 164.86% | -130.57% | 27.88% | -46.51% | 2111.63% | 213.91% | 182.87% | 38.6% | 92.76% | -240.56% | 70.53% |
| Net Income | -1.6M | -554K | -1.75M | -1.49M | -1.51M | -756K | 1.66M | 343K | -1.73M | -1.51M | -1.87M | -3.31M |
| Depreciation & Amortization | 511K | 546K | 544K | 563K | 539K | 543K | 543K | 549K | 545K | 550K | 564K | 170K |
| Stock-Based Compensation | 0 | 0 | 532K | 382K | 445K | 382K | 321K | 338K | 251K | 218K | 212K | 309K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.14M | 868K | 467K | 600K | 782K | 691K | 907K | 401K | 738K | 1.21M | 1.48M | 623K |
| Working Capital Changes | -210K | 1.43M | -1.1M | 1.79M | -3.74M | 5K | 840K | -189K | -2.18M | -510K | -4.14M | 463K |
| Change in Receivables | -682K | -61K | -244K | 1.59M | -1.38M | 586K | 1.96M | 254K | -193K | -1.54M | -3.95M | 610K |
| Change in Inventory | 369K | 904K | 257K | 885K | 733K | -1K | -319K | 190K | -202K | -385K | 1.56M | -219K |
| Change in Payables | 1.45M | 474K | 23K | -423K | -944K | 262K | -740K | -1.57M | 403K | 587K | -2M | 725K |
| Cash from Investing | -122K | -4.13M | -4.31M | -103K | -1K | -332K | -6.11M | 1.72M | -139K | 2.01M | -10.29M | -64K |
| Capital Expenditures | -425K | -86K | -229K | -164K | -63K | -395K | -191K | -286K | -139K | -43K | -16K | -80K |
| CapEx % of Revenue | 0% | 0.47% | 1.44% | 1.02% | 0.33% | 1.6% | 0.67% | 1.11% | 0.61% | 0.19% | 0.07% | 0.44% |
| Acquisitions | 175K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.36M | 0 |
| Cash from Financing | -813K | -1.06M | 6.74M | -650K | -783K | 2.79M | 2.31M | 2.06M | 178K | -742K | 12.85M | -130K |
| Debt Issued (Net) | -313K | -309K | -322K | -215K | -347K | -343K | -341K | -138K | -382K | -1.88M | -875K | -130K |
| Equity Issued (Net) | 0 | 0 | 7.82M | 0 | 0 | 3.79M | 3.63M | 2.2M | 560K | 1.1M | 13.76M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -500K | -750K | -750K | -435K | -436K | -653K | -976K | 0 | 0 | 38K | -43K | 0 |
| Net Change in Cash | -1.1M | -2.9M | 1.13M | 1.09M | -4.27M | 3.32M | 475K | 5.22M | -2.34M | 1.22M | -1.2M | -1.94M |
| Free Cash Flow | -592K | 2.21M | -1.54M | 1.68M | -3.55M | 470K | 4.08M | 1.16M | -2.52M | -86K | -3.77M | -1.82M |
| FCF Margin % | -0% | 12.02% | -9.64% | 10.45% | -18.77% | 1.91% | 14.42% | 4.48% | -11.11% | -0.39% | -15.86% | -10.07% |
| FCF Growth % | 83.32% | 369.15% | -137.61% | 45.33% | -40.93% | 646.51% | 208.36% | 163.52% | 37.35% | 87.32% | -209.19% | 69.44% |
| FCF per Share | -0.02 | 0.06 | -0.04 | 0.05 | -0.10 | 0.01 | 0.13 | 0.04 | -0.09 | -0.00 | -0.14 | -0.10 |
| FCF Conversion (FCF/Net Income) | 0.00x | -4.14x | 0.75x | -1.24x | 2.30x | -1.14x | 2.57x | 4.20x | 1.37x | 0.03x | 2.00x | 0.53x |
| Interest Paid | 0 | 0 | 0 | 190K | 190K | 202K | 213K | 198K | 234K | 280K | 634K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |